Human Apolipoprotein H Antibody (IgG) ELISA Kit (Sandwich ELISA)
Catalog Number: LS-F67372-1
1 plate / $591.00
Reactivity: Human
Detection Method Colorimetric
Format: 96-Well Strip Plate
Western blot analysis of 42278 expression in A549 (A); NS-1 (B); H9C2 (C) whole cell lysates.
SLC22A1 Antibody (C-Terminus)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunohistochemistry (general), Western Blot |
| Reactivity: | Human, Mouse, Rat |
| Format: | Liquid |
$261.00each
Catalog Number: LS-C354446-30
Catalog Number: LS-C354446
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- SLC22A1 antibody LS-C354446 is an unconjugated rabbit polyclonal antibody to SLC22A1 (C-Terminus) from human. It is reactive with human, mouse and rat. Validated for WB. Cited in 1 publication.
- Application
- IHC, WB
- Reactivity
- Hu, Ms, Rt
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- HOCT1 | OCT1 | Oct1_cds | Organic cation transporter 1 | SLC22A1
- Recommended Dilution: WB
- 1:500 - 1:1000
- UniProt Number
- O15245
- NCBI GenBank
- NM_003057 | NP_003048.1
- SwissProt
- O15245
Target
- Target
- Human SLC22A1
- Antigen Species
- Human
- Epitope
- Recognizes endogenous levels of OCT1/SLC22A1 protein.
- Gene Name
- SLC22A1
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the C-Terminus of human O15245
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.3, 0.01% Sodium Azide, 30% Glycerol
- Volume
- 30 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
- Recommended Storage Buffer
- PBS
Mapping of biguanide transporters in human fat cells and their impact on lipolysis. Peter Arner, Agné Kulyté, Kenneth Batchelor, Jurga Laurencikiene, James Livingston, Mikael Rydén. Diabetes, obesity & metabolism. 2018 October;20:2416-2425. PubMed: 29862627 PMC: PMC6133731
